Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Valued at a market capitalization of $54.4 billion, Parsippany, New Jersey-based Zoetis Inc. (ZTS) is a leader in the animal health space and is engaged in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions in the United States and internationally. 

Companies with a market cap of $10 billion or more are typically referred to as “large-cap stocks.” Zoetis sits comfortably there, with its market cap exceeding this threshold, reflecting its scale, dominance, and staying power.

Fundamentals

See More
  • Market Capitalization, $K 55,340,980
  • Shares Outstanding, K 422,128
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,488 M
  • EBITDA $ 3,975 M
  • 60-Month Beta 0.96
  • Price/Sales 5.85
  • Price/Cash Flow 17.15
  • Price/Book 17.17

Options Overview Details

View History
  • Implied Volatility 29.22% (+1.78%)
  • Historical Volatility 23.23%
  • IV Percentile 52%
  • IV Rank 27.87%
  • IV High 46.55% on 04/07/25
  • IV Low 22.52% on 08/12/25
  • Expected Move (DTE 20) 5.93 (4.53%)
  • Put/Call Vol Ratio 0.44
  • Today's Volume 891
  • Volume Avg (30-Day) 3,161
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 60,818
  • Open Int (30-Day) 66,501
  • Expected Range 125.17 to 137.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.62
  • Number of Estimates 10
  • High Estimate 1.69
  • Low Estimate 1.55
  • Prior Year 1.48
  • Growth Rate Est. (year over year) +9.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.94 +10.22%
on 02/12/26
132.49 -1.05%
on 02/12/26
+6.14 (+4.91%)
since 01/27/26
3-Month
115.59 +13.42%
on 12/09/25
132.49 -1.05%
on 02/12/26
+3.41 (+2.67%)
since 11/26/25
52-Week
115.25 +13.75%
on 11/19/25
177.00 -25.93%
on 03/10/25
-33.88 (-20.54%)
since 02/27/25

Most Recent Stories

More News
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.

XLV : 160.20 (+1.77%)
ZTS : 131.10 (+1.03%)
UTHR : 503.90 (+0.06%)
2 Reasons to Like ZTS (and 1 Not So Much)

2 Reasons to Like ZTS (and 1 Not So Much)

ZTS : 131.10 (+1.03%)
Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2026 Animal Health Summit on Thursday, February 26, 2026 at 1:15 p.m. ET. Wetteny Joseph, Executive Vice President and...

ZTS : 131.10 (+1.03%)
The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

ZTS : 131.10 (+1.03%)
2 S&P 500 Stocks to Research Further and 1 We Question

2 S&P 500 Stocks to Research Further and 1 We Question

WM : 240.84 (+2.97%)
GM : 78.71 (-2.57%)
ZTS : 131.10 (+1.03%)
3 S&P 500 Stocks Worth Investigating

3 S&P 500 Stocks Worth Investigating

TT : 462.32 (+1.13%)
BSX : 76.85 (+1.45%)
ZTS : 131.10 (+1.03%)
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook

ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook

ZTS : 131.10 (+1.03%)
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates

Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates

ZTS : 131.10 (+1.03%)
Zoetis: Q4 Earnings Snapshot

Zoetis: Q4 Earnings Snapshot

ZTS : 131.10 (+1.03%)
Zoetis Reports Fourth Quarter and Full Year 2025 Results

Reports Revenue of $2.4 Billion, Growing 3%, and Net Income of $603 Million, or $1.37 per Diluted Share, Increasing 4% and 6%, Respectively, on a Reported Basis for Fourth Quarter 2025 ...

ZTS : 131.10 (+1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 136.90
2nd Resistance Point 134.60
1st Resistance Point 132.85
Last Price 131.10
1st Support Level 128.80
2nd Support Level 126.50
3rd Support Level 124.75

See More

52-Week High 177.00
Fibonacci 61.8% 153.41
Fibonacci 50% 146.13
Fibonacci 38.2% 138.84
Last Price 131.10
52-Week Low 115.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar